RESUMO

Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandrogenic agents, melatonin, and the antimalarial drugs chloroquine and hydroxychloroquine. These and other agents, some of which have proven controversial, are being scrutinized by the scientific community. We briefly review the aforementioned dermatologic drugs and describe the most recent findings relevant to their use against COVID-19.

Assuntos

Tratamento Farmacológico da COVID-19 , SARS-CoV-2 , Antagonistas de Androgênios/farmacologia , Antagonistas de Androgênios/uso terapêutico , Antimaláricos/farmacologia , Antimaláricos/uso terapêutico , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Antiparasitários/farmacologia , Antiparasitários/uso terapêutico , COVID-19/mortalidade , Cloroquina/farmacologia , Cloroquina/uso terapêutico , Cinchona/química , Humanos , Hidroxicloroquina/farmacologia , Hidroxicloroquina/uso terapêutico , Ivermectina/farmacologia , Ivermectina/uso terapêutico , Melatonina/farmacologia , Melatonina/uso terapêutico , Internalização do Vírus/efeitos dos fármacos